Negative Association between Testosterone Concentration and Inflammatory Markers in Young Men: A Nested Cross-Sectional Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Bobjer, Johannes ^a,b   Katrinaki, Marianna ^c   Tsatsanis, Christos ^c   Lundberg Giwercman, Yvonne ^b   Giwercman, Aleksander ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; INTERFERON GAMMA INDUCED PROTEIN 10; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; LUTEINIZING HORMONE; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1 BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; INFLAMMATION; LOW GRADE SYSTEMIC INFLAMMATION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CHEMOKINE CCL3; CROSS-SECTIONAL STUDIES; ESTRADIOL; HUMANS; HYPOGONADISM; INFERTILITY, MALE; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876326351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061466     Document Type: Article

References (29)

1. Phillips GB, Pinkernell BH, Jing TY, (1994) The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 14: 701-706.
2. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB, (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23: 490-494.
3. Haffner SM, Mykkanen L, Valdez RA, Katz MS, (1993) Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metab 77: 1610-1615.
4. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27: 1036-1041.
5. Tracy RP (2003) Inflammation, the metabolic syndrome and cardiovascular risk. Int J Clin Pract Suppl: 10-17.
6. Rotter V, Nagaev I, Smith U, (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278: 45777-45784.
7. Brown MS, Goldstein JL, (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52: 223-261.
8. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
9. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, et al. (2002) Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87: 3632-3639.
10. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, et al. (2004) Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109: 2074-2079.
11. Rosano GM, Sheiban I, Massaro R, Pagnotta P, Marazzi G, et al. (2007) Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res 19: 176-182.
12. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM, (2011) Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 97: 870-875.
13. Jones TH, Saad F, (2009) The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 207: 318-327.
14. D'Agostino P, Milano S, Barbera C, Di Bella G, La Rosa M, et al. (1999) Sex hormones modulate inflammatory mediators produced by macrophages. Ann N Y Acad Sci 876: 426-429.
15. Li ZG, Danis VA, Brooks PM, (1993) Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 11: 157-162.
16. Liva SM, Voskuhl RR, (2001) Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 167: 2060-2067.
17. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, et al. (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 89: 3313-3318.
18. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, et al. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf) 73: 602-612.
19. Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, et al. (2004) Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 10: 409-419.
20. Vermeulen A, Verdonck L, Kaufman JM, (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666-3672.
21. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, et al. (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
22. Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, et al. (2007) Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 92: 4254-4259.
23. Kupelian V, Chiu GR, Araujo AB, Williams RE, Clark RV, et al. (2010) Association of sex hormones and C-reactive protein levels in men. Clin Endocrinol (Oxf) 72: 527-533.
24. Khosla S, Atkinson EJ, Dunstan CR, O'Fallon WM, (2002) Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab 87: 1550-1554.
25. Maggio M, Basaria S, Ble A, Lauretani F, Bandinelli S, et al. (2006) Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 91: 345-347.
26. Ruige JB, Bekaert M, Lapauw B, Fiers T, Lehr S, et al. (2012) Sex steroid-induced changes in circulating monocyte chemoattractant protein-1 levels may contribute to metabolic dysfunction in obese men. J Clin Endocrinol Metab 97: E1187-1191.
27. Pikwer M, Giwercman A, Bergström U, Nilsson J, Jacobsson L, et al. (2013) Association between testosterone levels and risk of future rheumatoid arthritis in men - a population based case-control study. Ann Rheum Dis. In press.
28. Vermeulen A, Kaufman JM, Giagulli VA, (1996) Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81: 1821-1826.
29. Bjorkbacka H, Fredrikson GN, Nilsson J, (2012) Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis- A review of the experimental evidence. Atherosclerosis 227(1): 9-17.